CD8A and ovarian cancer: In line with previous findings in colon and ovarian cancer models, we observed that oncolytic viroimmunotherapy could upregulate the expression of PD-L1 and enhance the proportion of PD-1+CD8 T cells in the tumor microenvironment (35, 36) (Supplementary Figures 1A, B).